Granules India Limited (GRANULES.NS)
INR 596.4
(-0.07%)
INR 596.4
(-0.07%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 13 Billion INR | 13.15% |
| 2022 | 11.49 Billion INR | 17.46% |
| 2021 | 9.78 Billion INR | 25.11% |
| 2020 | 7.82 Billion INR | 78.4% |
| 2019 | 4.38 Billion INR | 14.11% |
| 2018 | 3.84 Billion INR | 37.25% |
| 2017 | 2.79 Billion INR | 1.4% |
| 2016 | 2.76 Billion INR | -10.09% |
| 2015 | 3.07 Billion INR | 36.76% |
| 2014 | 2.24 Billion INR | 28.91% |
| 2013 | 1.74 Billion INR | 27.61% |
| 2012 | 1.36 Billion INR | 24.18% |
| 2011 | 1.09 Billion INR | 46.3% |
| 2010 | 751.27 Million INR | 9.46% |
| 2009 | 686.33 Million INR | 15.33% |
| 2008 | 595.1 Million INR | 12.57% |
| 2007 | 528.63 Million INR | 78.59% |
| 2006 | 295.99 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 12.79 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 13 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 13 Billion INR | 13.15% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 11.49 Billion INR | 17.46% |
| 2022 Q2 | 11.62 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 11.49 Billion INR | 0.0% |
| 2021 FY | 9.78 Billion INR | 25.11% |
| 2021 Q2 | 8.93 Billion INR | 0.0% |
| 2021 Q4 | 9.78 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 7.82 Billion INR | 78.4% |
| 2020 Q4 | 7.82 Billion INR | 0.0% |
| 2020 Q2 | 6.2 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q2 | 3.8 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 4.38 Billion INR | 14.11% |
| 2019 Q4 | 4.38 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 3.84 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 3.88 Billion INR | 0.0% |
| 2018 FY | 3.84 Billion INR | 37.25% |
| 2017 Q2 | 2.88 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 2.79 Billion INR | 1.4% |
| 2017 Q4 | 2.79 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 2.76 Billion INR | 0.0% |
| 2016 FY | 2.76 Billion INR | -10.09% |
| 2016 Q2 | 2.33 Billion INR | 0.0% |
| 2015 Q4 | 3.07 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 3.07 Billion INR | 36.76% |
| 2015 Q2 | 2.57 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 2.32 Billion INR | 0.0% |
| 2014 FY | 2.24 Billion INR | 28.91% |
| 2014 Q4 | 2.24 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q2 | 1.62 Billion INR | 0.0% |
| 2013 Q4 | 1.74 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 1.74 Billion INR | 27.61% |
| 2012 FY | 1.36 Billion INR | 24.18% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q4 | 1.36 Billion INR | 0.0% |
| 2012 Q2 | 2.55 Billion INR | 0.0% |
| 2011 FY | 1.09 Billion INR | 46.3% |
| 2010 FY | 751.27 Million INR | 9.46% |
| 2009 FY | 686.33 Million INR | 15.33% |
| 2008 FY | 595.1 Million INR | 12.57% |
| 2007 FY | 528.63 Million INR | 78.59% |
| 2006 FY | 295.99 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Sigachi Industries Limited | 707.2 Million INR | -1738.988% |
| Ind-Swift Limited | 640.91 Million INR | -1929.2% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -802.917% |
| Sakar Healthcare Limited | 277.32 Million INR | -4589.64% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 86.74% |
| Innova Captab Limited | 1.44 Billion INR | -803.056% |
| Divi's Laboratories Limited | 31.84 Billion INR | 59.154% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -470.71% |
| Morepen Laboratories Limited | 2.48 Billion INR | -423.16% |
| Mankind Pharma Limited | 15.53 Billion INR | 16.281% |
| Sequent Scientific Limited | 3.46 Billion INR | -275.628% |
| Wanbury Limited | 360.23 Million INR | -3510.298% |
| Laurus Labs Limited | 18.45 Billion INR | 29.525% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -83.395% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -95.104% |
| Alembic Limited | 113.4 Million INR | -11368.651% |
| Hikal Limited | 3.03 Billion INR | -328.205% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 20.869% |
| Neuland Laboratories Limited | 3.5 Billion INR | -271.137% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -158.81% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 48.248% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -206.126% |
| Themis Medicare Limited | 705.74 Million INR | -1742.803% |
| RPG Life Sciences Limited | 1.01 Billion INR | -1187.668% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 62.214% |
| Lupin Limited | 49.53 Billion INR | 73.747% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -4399.424% |
| Wockhardt Limited | 6.4 Billion INR | -103.21% |
| Vaishali Pharma Limited | 3.79 Million INR | -342419.094% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -102.306% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -8572.034% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -0.849% |
| FDC Limited | 3.88 Billion INR | -234.426% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 79.536% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -32511.459% |
| Eris Lifesciences Limited | 1.89 Billion INR | -588.003% |
| Venus Remedies Limited | 1.21 Billion INR | -968.736% |
| ZIM Laboratories Limited | 812.62 Million INR | -1500.417% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -997.995% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -31035.863% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | -258.237% |
| Shilpa Medicare Limited | 3.44 Billion INR | -277.048% |
| Albert David Limited | 436.12 Million INR | -2882.074% |
| Ajanta Pharma Limited | 8.28 Billion INR | -57.002% |
| Hester Biosciences Limited | 755.81 Million INR | -1620.73% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -462.53% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -261.564% |
| Gufic Biosciences Limited | 2 Billion INR | -548.709% |
| Windlas Biotech Limited | 621.89 Million INR | -1991.278% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -1091.958% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -3650.591% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -951.882% |
| Aarti Drugs Limited | 4.85 Billion INR | -167.662% |
| Bal Pharma Limited | 878.11 Million INR | -1381.066% |
| Alkem Laboratories Limited | 26.61 Billion INR | 51.129% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 86.821% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -1585.34% |
| Medicamen Biotech Limited | 593.75 Million INR | -2090.384% |
| Unichem Laboratories Limited | 7.04 Billion INR | -84.559% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -4287.537% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -50907.766% |
| Valiant Laboratories Limited | 100.15 Million INR | -12885.452% |
| Orchid Pharma Limited | 2.64 Billion INR | -392.209% |
| Medico Remedies Limited | 163.37 Million INR | -7860.636% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -12336.243% |
| Ipca Laboratories Limited | 24.71 Billion INR | 47.374% |
| Brooks Laboratories Limited | 96.1 Million INR | -13432.12% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -6069.129% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 42.934% |
| NATCO Pharma Limited | 7 Billion INR | -85.66% |
| Suven Life Sciences Limited | 7.08 Million INR | -183463.162% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -13175.744% |
| Strides Pharma Science Limited | 11.26 Billion INR | -15.477% |
| Indoco Remedies Limited | 3.53 Billion INR | -268.364% |
| Alpa Laboratories Limited | 136.65 Million INR | -9417.135% |
| Lasa Supergenerics Limited | 190.43 Million INR | -6729.374% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -87822.188% |